T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Financials | 10.75% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Xencor
XNCR
$1.86B
| $156M | 0.02% |
5,854,502
-54,181
| -0.9% | -$1.75M |
|
602
Jacobs Solutions
J
$16B
| $155M | 0.02% |
1,363,635
-2,225,004
| -62% | -$239M |
|
603
Brighthouse Financial
BHF
$3B
| $154M | 0.02% |
2,987,271
-1,533,491
| -34% | -$81.8M |
|
604
Fox Class B
FOX
$23.8B
| $154M | 0.02% |
4,247,775
-4,077,983
| -49% | -$152M |
|
605
C.H. Robinson
CHRW
$17.1B
| $154M | 0.02% |
1,427,983
-146,605
| -9% | -$14.9M |
|
606
Nucor
NUE
$55.6B
| $153M | 0.02% |
1,029,053
+146,445
| +17% | +$18M |
|
607
WSFS Financial
WSFS
$3.92B
| $152M | 0.02% |
3,263,774
+26,507
| +0.8% | +$1.37M |
|
608
BellRing Brands
BRBR
$902M
| $152M | 0.02% |
6,586,611
+4,218,607
| +178% | +$106M |
|
|
EA
609
DELISTED
Electronic Arts
EA
| $151M | 0.02% |
1,195,820
+40,122
| +3% | +$5.22M |
|
610
Steel Dynamics
STLD
$33.1B
| $151M | 0.02% |
1,812,275
+431,456
| +31% | +$29.1M |
|
611
Enerpac Tool Group
EPAC
$1.8B
| $150M | 0.02% |
6,868,437
-55,282
| -0.8% | -$1.05M |
|
612
Ollie's Bargain Outlet
OLLI
$5.02B
| $150M | 0.02% |
3,487,825
-150,034
| -4% | -$6.7M |
|
613
Target
TGT
$71.9B
| $150M | 0.02% |
705,363
-41,965
| -6% | -$9.08M |
|
614
Relay Therapeutics
RLAY
$3.86B
| $150M | 0.02% |
4,999,718
+844,377
| +20% | +$20.5M |
|
615
McCormick & Company Non-Voting
MKC
$12.9B
| $149M | 0.02% |
1,492,065
-272,058
| -15% | -$26.6M |
|
616
Gilead Sciences
GILD
$188B
| $149M | 0.02% |
2,501,705
-228,171
| -8% | -$14.6M |
|
617
PPG Industries
PPG
$23.6B
| $148M | 0.01% |
1,130,307
-426,532
| -27% | -$62M |
|
618
Lam Research
LRCX
$389B
| $148M | 0.01% |
2,750,590
-4,219,630
| -61% | -$246M |
|
619
MaxLinear
MXL
$8.01B
| $148M | 0.01% |
2,533,332
-121,916
| -5% | -$7.42M |
|
|
RNAM
620
DELISTED
Avidity Biosciences
RNAM
| $147M | 0.01% |
7,985,535
+253,689
| +3% | +$4.31M |
|
621
Pinduoduo
PDD
$112B
| $147M | 0.01% |
3,654,218
-4,187,389
| -53% | -$215M |
|
622
Surgery Partners
SGRY
$1.9B
| $147M | 0.01% |
2,661,921
-148,159
| -5% | -$7.33M |
|
|
BWIN
623
Baldwin Insurance Group
BWIN
$3.08B
| $146M | 0.01% |
5,449,663
+629,228
| +13% | +$18.1M |
|
|
NARI
624
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $146M | 0.01% |
1,609,993
+490,718
| +44% | +$40.2M |
|
|
AIV
625
Aimco
AIV
$315M
| $146M | 0.01% |
19,903,350
-1,959,689
| -9% | -$13.9M |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.